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Abstract
Background: In mental health settings, implementation of and adherence to clinical practice guidelines (CPGs) is
low. Strategies are needed to overcome barriers and facilitate successful implementation of CPGs into standard
care. The goals of this study were to develop a framework for the implementation of a CPG for schizophrenia for
hospitalized service users in a mental health care facility, and to monitor adherence to the guideline.
Methods: An eight-step framework was developed based on project management principles: 1) the Appraisal
Guideline for Research and Evaluation (AGREE) tool was used to rate and select a CPG; 2) an algorithm was created
from the guideline; 3) a gap analysis identified clinical services and processes not conforming with the CPG
recommendations; 4) a governance structure was created; 5) a modified Delphi process determined key outcome
and process adherence metrics; 6) a project charter was developed; 7) clinical informatics ensured that systems and
tools were in place to support the CPG; and 8) therapeutic services were realigned to match the requirements of
the CPG within specified fiscal constraints. Percent adherence to the identified process adherence metrics was
calculated before (March 2014) and for 12 months after implementation (April 2014-March 2015).
Results: The National Institute of Health and Care Excellence guideline scored highest on AGREE and was used to
develop the algorithm. Cognitive behavior therapy for psychosis (CBT-P), art therapy and carer assessments were
identified as gaps in care. Clinical global impression – Schizophrenia score was identified as the primary service user
outcome variable and antipsychotic polypharmacy, metabolic monitoring, CBT-P referral and supported
employment/vocational services referral as the primary process adherence measures. Adherence to guidance for
metabolic monitoring (March 2014, 76.7 %; March 2015, 81.6 %), CBT-P referral (March 2014, 6.5 %; March 2015, 11.
4 %) and vocational rehabilitation referral (March 2014, 36.6 %; March 2015, 49.1 %) were increased after CPG
implementation. There was an initial increase in adherence to antipsychotic monotherapy (March 2014, 53.4 %;
November 2014, 62.7 %), which decreased back toward baseline (March 2015, 55.1 %).
Conclusions: The eight-step framework was used to implement a CPG process, though further quality
improvements initiatives may be needed to improve adherence.
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Background
Clinical practice guidelines (CPGs) are developed based on
a synthesis of scientific evidence regarding the best ap-
proaches for the assessment, diagnosis and treatment of a
particular clinical domain or diagnosis in order to optimize
care [1]. Research examining adherence to CPGs in the
mental health sector has shown mixed results [2–10], and
most studies report adherence to only one component of
the guideline. Results from physician surveys have identified
a number of barriers to the adoption of, and adherence to,
CPGs including: lack of awareness of or disagreement with
guidelines; insufficient motivation to change; negative
attitudes toward guidelines in general; faith in existing
treatment practices; and lack of time, availability and
organizational support [11, 12]. The local context has been
identified as an important factor in determining the success
of CPG implementation [11]. For example, organizational
culture and leadership, evaluation of practices and perform-
ance feedback are important facilitators to implementation
[11]. Thus, a systematic implementation of a CPG at the
organizational level targeting common barriers could lead
to better adherence. A recent review determined that multi-
faceted implementation strategies including educational
materials or meetings along with reminders and coordin-
ation by a member of the healthcare team were most likely
to improve adherence following CPG implementation [13].
Ontario Shores Centre for Mental Health Sciences’
(Ontario Shores) 5-year strategic plan includes the sys-
tematic implementation of CPGs with the goal of ensur-
ing that service users and families are provided with the
full complement of assessments and treatments recom-
mended by CPGs. Ontario Shores considered CPG im-
plementation as an opportunity to become a data driven
organization, using clinical measures to drive quality im-
provement and improve outcomes for service users. The
first CPG to be implemented at Ontario Shores was for
the assessment and treatment of schizophrenia and schi-
zoaffective disorder for hospitalized service users. It was
recognized that an organization-wide strategy with
strong leadership aimed at facilitating implementation
while overcoming common barriers would be essential
for success [11–13]. The purpose of this paper was to
describe the implementation of CPGs for schizophrenia
and schizoaffective disorder at Ontario Shores and to
present CPG adherence data over the 12 months follow-
ing implementation.
Methods
This observational study was carried out as a corporate
evaluation initiative at Ontario Shores (Whitby, Canada),
a 326-bed public teaching hospital specializing in com-
prehensive mental health and addiction services for
those with complex serious and persistent mental illness.
CPG-recommended treatments were to be applied to
any service user admitted to a general adult or forensic
unit with a primary diagnosis of schizophrenia or schi-
zoaffective disorder.
Two types of working groups were formed to support
implementation: The Physicians representing each clin-
ical program within the organization were appointed to
the Physician-Advisory Group on the basis of interest,
clinical expertise and leadership. Representatives from
Clinical Informatics and Professional Practice were in-
cluded in this committee. The interprofessional design
working groups included the Medical Director of Clin-
ical Informatics (a psychiatrist), representatives from
Professional Practice and Decision Support, the manager
and representatives from Clinical Informatics, and at
least one point-of-care professional from each health
care profession affected by the changes. Members were
identified based on their expertise and willingness to
champion the changes to their colleagues. Ideally, ser-
vice users and their carers would have been included in
design working groups, but at the time of implementa-
tion, the organization had neither a structured process
in place to recruit service users or carers nor a strategy
to ensure meaningful participation of service users and
carers.
An eight-step framework based on project manage-
ment principles [14] was developed for the implementa-
tion of a CPG for schizophrenia. The goals of the project
were to leverage the electronic medical record (EMR) to
integrate CPGs consistently into practice; involve point
of care staff in the development of new processes; ensure
that mechanisms were in place to monitor adherence to
guideline recommendations; and realign existing re-
sources to meet the guideline-derived clinical service of-
ferings with no additional funding in order to achieve
long-term sustainability in an environment of cost
constraint.
Step 1: clinical practice guideline selection
The internationally-recognized Appraisal Guidelines for Re-
search and Evaluation (AGREE) instrument consists of 23
items to assess the quality of a CPG based on six domains:
scope and purpose; stakeholder involvement; rigor of devel-
opment; clarity and presentation; applicability; and editorial
independence [15]. Gaebel and colleagues [16] reviewed
and assessed five CPGs for the assessment and treatment of
schizophrenia using the AGREE tool [The Royal Australian
and New Zealand College of Psychiatrists; American Psy-
chiatric Association; The German Association of Psychiatry,
Psychotherapy and Psychosomatics; National Institute for
Health and Care Excellence (NICE), Department of Health,
United Kingdom; and The Schizophrenia Patient Outcomes
Research Team, National Institute of Mental Health, United
States]. Although the Canadian Psychiatric Association’s
guideline was not included in the appraisal since the 1998
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version scored low in a previous review [17], we considered
the updated Canadian CPG [18], which was scored by a
working group of local clinicians. The CPG that AGREE
ranked highest overall was selected for implementation at
Ontario Shores.
Step 2: algorithm development
The selected guideline was reviewed and an algorithm
was created for the assessment and treatment of schizo-
phrenia for hospitalized service users, specifically and
exclusively for the CPG. The work of distilling the full
guideline into a succinct clinical algorithm was com-
pleted by the Physician Advisory Group to ensure that
the new processes would be feasible with their workflow.
The algorithm was built to cover all aspects of care from
admission to discharge, including interventions for ser-
vice users and their carers, as per the CPG.
Step 3: gap analysis
A team of psychiatrists, interprofessional clinicians and in-
formatics personnel conducted a gap analysis by creating
a flowchart of our current state of treatment for persons
with schizophrenia and comparing it with NICE-derived
future-state processes depicted by the algorithm. Current
processes that were not in accordance with the CPG were
identified and a plan was made to operationalize missing
assessment and treatment practices.
Step 4: create governance structure
A governance structure was developed to support CPG im-
plementation (Fig. 1). This project was initiated as an out-
come of senior management’s strategic plan, which was
approved by Ontario Shores’ Board of Directors. Interpro-
fessional design working groups reported to a steering com-
mittee, which was sponsored by the Vice-President of
Medical Affairs and the Chief Nursing Officer; co-led by
the Medical Director of Clinical Informatics (physician
lead) and the Director of Professional Practice; and was
composed of the Directors of Human Resources, Clinical
Information, Project Management Office and Decision sup-
port, the administrative director of an inpatient unit, the
Managers of Communications, Clinical Information and
Pharmacy, the Clinical Manager of the Integrated Commu-
nity Access Program and a Clinical Nurse Specialist from
an inpatient unit. The physician lead was co-chair of the
steering committee in addition to chair of the Physician
Advisory Group and a member of the Medical Advisory
Committee. Appropriate stakeholders were embedded into
the governance structure to mitigate risk and to encourage
ownership for the success of the initiative. Assumptions
and constraints analysis was performed by the steering
committee to validate assumptions and identify constraints
and risk.
Step 5: selection of key process adherence and outcome
measures
The Physician Advisory Group used a modified Delphi
Process to select key process adherence and outcome
measures. The Physician lead developed a list of all pos-
sible adherence measures captured in the EMR and con-
ducted a literature search for clinical outcomes in
schizophrenia. This step was designed for inclusiveness, so
all common outcome scales and applicable measures were
included. The team reviewed the filtered list and discussed
feasibility and Donabedian classifications [19] of each po-
tential measure. Each member of the group independently
scored each metric according to the five National Quality
Forum criteria: importance, scientific acceptability, feasi-
bility, usability, and related and competing measures [20].
Each was classified as being of high, medium or low im-
portance based not only on their ability to indicate change
in symptomatology, but recovery (e.g. improvements in
relationships, level of functioning, ability to formulate and
achieve goals). Mean scores for each domain were pre-
sented to the group. Low scoring metrics with limited
feasibility or competing measures were discussed and
rescored if necessary. The one outcome and four adher-
ence measures that ranked highest were chosen as the pri-
mary quality assurance metrics, which populate a clinical
dashboard that would be sent to every physician and clin-
ical leader in the organization.
Step 6: project charter development
A project charter, created by the physician lead included
the scope of the project, accountabilities, executive
sponsorship, timelines, budget and escalation strategies.
Step 7: utilization of informatics
Informatics was included in all planning activities from
the onset of the project to ensure that technology was
Fig. 1 Governance structure developed for clinical practice guideline
implementation. CPG, Clinical Practice Guideline; MAC, Medical
Advisory Committee; SMT, Senior Management Team
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leveraged to enable successful CPG implementation.
Current and future-state work-flows were documented
using process maps. Electronic clinical documentation
tools for physicians, nurses and allied healthcare staff
were revised in accordance with the findings of the gap
analysis. Order sets and clinical panels (i.e. groups of
tests routinely ordered to determine health status – for
example, lipid panel for metabolic monitoring) were re-
vised to align with the CPG. Extensive clinical decision
support was embedded within the EMR to promote
CPG adherence by building rules within the system
whereby certain interventions and orders were automat-
ically suggested when clinicians documented certain
items within their templates. Online tools were devel-
oped for staff education to increase awareness of the
CPG and aid in the transition.
Step 8: realignment of therapeutic services
Decision documents for service realignment were cre-
ated by clinical working groups to outline options for re-
source re-allocation for the purposes of operationalizing
the guideline. Decision documents detailed the pros and
cons of various options for operationalizing each recom-
mendation, with consideration including resource use,
cost, degree of clinical restructuring, local expertise,
training needs and potential consequences to service
users (i.e. clinical outcome, loss of service not included
in the CPG, etc.). These were presented to senior man-
agement for final selection and approval. In order for
this process to remain cost-neutral, the hiring of new
personnel was out of scope for this project. Therapeutic
Recreation was the discipline most affected by the clin-
ical service delivery changes with CPG-recommended
treatments replacing non-CPG activities. All training oc-
curred during normal work hours to maintain neutral
cost.
Dissemination
Clinical dashboards were developed for physicians, clin-
ical managers, clinical nurse specialists and administra-
tive directors. These were compiled in the EMR and
pushed out monthly for each physician and program to
view their adherence to the prioritized metrics and com-
pare them to hospital averages and other units (Fig. 2).
They could not see the adherence of individual physi-
cians. This dissemination strategy commenced May
2014 (i.e. following the first month of implementation)
and continued throughout the follow-up period.
Data processing
To ensure sustainability, all data processing was com-
pleted through data contained within the EMR; hence, all
variables had to be accessible in the EMR. Adherence data
was examined for the key process adherence metrics
identified by the modified Delphi Process. Baseline was
calculated from March 2014 (the month prior to imple-
mentation of the CPG) and monthly adherence was calcu-
lated for the 12 months following implementation (April
2014-March 2015). Adherence to antipsychotic polyphar-
macy guidelines was calculated as the percentage of ser-
vice users, at the end of each month, prescribed only one
antipsychotic (or any antipsychotic medication in combin-
ation with clozapine as per the NICE CPG [21]). Adher-
ence to metabolic monitoring was calculated as the
percent of metabolic risk appraisal measures (waist cir-
cumference, body mass index and blood pressure every
30 days; glycated hemoglobin lipid panel annually) moni-
tored at the recommended intervals. Adherence to CBT-P
referral was calculated as the percent of service users with
schizophrenia who had been referred for CBT-P. Adher-
ence to referral for supported employment was estimated
as the percent of service users who had been referred to
the vocational services, which served as a proxy measure.
Referral was selected as a proxy rather than attendance of
CBT-P or vocational rehabilitation services as referrals
were completed through the EMR, while attendance was
not captured as a discrete data component and was there-
fore not easily accessible for tracking. Additionally, since
the adherence of interest was that of the clinician, not the
service users, it was decided that referral would reflect this
best. Descriptive analysis of the change in monthly sum-
mary data was completed. Data are presented as percent
CPG adherence, unless otherwise stated.
Results
AGREE analysis
Based on the CPG review completed by Gaebel et al. [16]
and the review of the Canadian Psychiatric Association
guidelines completed by Ontario Shores’ clinicians, the
NICE CPG for assessment and treatment of schizophrenia
[21] was selected, as it was the highest ranked CPG accord-
ing to the AGREE analysis with a total score of 90 [16].
Gap analysis
The three identified clinical service gaps were lack of stan-
dardized art therapy, lack of carer assessment, and low
capacity for CBT-P. Important opportunities for documen-
tation standardization and the building of automated
decision-support were also identified, but other major CPG
treatment recommendations such as smoking cessation,
diet and exercise were already standard treatments at
Ontario Shores. A tracking template for psychopharmaco-
logic trials over the course of a service-user’s illness, auto-
mated decision-support tools to promote adherence to the
recommended metabolic monitoring protocols and refer-
rals to evidence-based non-pharmacologic treatments such
as CBT-P and vocational services, exception handling re-
quiring physicians to enter a “reason” when prescribing
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multiple antipsychotics, and links to educational pamphlets
for service-users were created.
Process adherence and outcome measures
The modified Delphi process identified the Clinical Glo-
bal Impression Scale for Schizophrenia as the priority
metric for quantifying service user outcomes (Table 1).
Four process adherence measures were identified, with
percentage of service users on multiple antipsychotics
(excluding clozapine as the second antipsychotic) ranked
as number one, followed by percentage of service users
with all five metabolic risk factors monitored at recom-
mended intervals, percentage of service users who had
been referred for supported employment/vocational ser-
vices, and percentage of service users who had been re-
ferred to CBT-P.
Realignment of services
NICE guidance recommends offering 1:1 CBT-P for all ser-
vice users with schizophrenia. Although this was one of
the recommendations in the prepared decision document,
it was not feasible to implement this in a cost-neutral way.
Resources were realigned to ensure that referral to group
CBT-P was available for all service users with schizophre-
nia and that 1:1 CBT-P could be offered if a service user
did not respond to or was not suitable for the group for-
mat. Specifically, a CBT-P manual was chosen, a number
of psychologists were trained in the provision of CBT-P,
supervision groups were implemented, and decision-
support was added such that a referral to CBT-P was sug-
gested every time an admitting physician documented that
a service user had schizophrenia as a primary diagnosis.
Only referral to group CBT-P was captured in the EMR
data. Clinicians indicated that they believed many service
users were too ill or disorganized at the time of admission
to benefit from a CBT-P group and as a result, often de-
selected the recommended order that was triggered at ad-
mission. Standardized art therapy, including the modalities
of music, visual art and drama/dance therapy, is recom-
mended in the NICE guideline as an important interven-
tion for service users with schizophrenia to reduce
negative symptoms [21]. A decision document was created
Fig. 2 Clinical score card developed to provide clinicians with feedback regarding adherence to guidelines. ASU, PRA, PRB, YNG ADLTS, ARP, AYA,
Forensic, GNP represent different units at Ontario Shores. BMI, body mass index; BP, blood pressure; CBT, cognitive behavioral therapy; CGI,
Clinical Global Index; Cloz., Clozapine; HbA1c, glycated hemoglobin
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outlining various options for implementing standardized
art therapy modules. Prior to CPG implementation, music
and art were already included as therapeutic recreation ac-
tivities. Since training and clinical supervision resources
were already secured, music therapy was formalized ac-
cording to the CPG. Art continued to be used as a thera-
peutic modality, but not in a formalized program.
Carer support is recommended as an intervention in
the treatment of schizophrenia. Verbal consent by ser-
vice users (documented in the EMR) was required for
carer involvement in care. In order to conform to the
NICE CPG, enhancements were added to the existing
processes. A standardized template was created in the
EMR for a carer assessment to be completed by social
workers during their work with carers (Fig. 3). Addition-
ally, a number of standard carer support group interven-
tions were made available and referral to the Family
Resource Centre was prioritized.
Ontario Shores had already implemented a robust sup-
ported employment program and it was identified that
additional resources were not likely required at the time
of CPG implementation. Hence, it was decided that ad-
herence to vocational services referral would be tracked
and processes to improve adherence would be imple-
mented if needed.
Adherence data
CPG adherence data from the month prior to imple-
mentation (March 2014) and the 12 months follow-
ing implementation (April 2014-March 2015) are
shown in Fig. 4. In March 2014, 53.4 % of service
users were prescribed monotherapy (range across
units 18.7–100 %), which increased to 62.7 % in No-
vember 2014 (range across units 27.3–100 %) and
decreased back toward baseline by March 2015
(55.1 %; range across units 22.7–100 %), showing an
overall 5.8 % increase over the follow-up period. In
March 2014, 76.7 % of metabolic syndrome risk fac-
tors were monitored at the recommended intervals
(range across units 60.0–90.0 %). There was a 6.3 %
increase over the 12 month follow-up to 81.6 % ad-
herence in March 2015 (range across units 0–100 %:
note that the unit with 0 % had only one service
user who met inclusion criteria). Referrals to CBT-P
increased 74.8 % from 6.5 % (range across units 0–
27.3 %) in March 2014 to 11.4 % (range across units
0–23.1 %) in March 2015. The percentage of service
users referred to vocational rehabilitation increased
34.2 % from 36.6 % (range across units 0–81.3 %) in
March 2014 to 49.1 % (range across units 0–76.2 %)
in March 2015.
Table 1 Service user outcome and process adherence metric selection via modified Delphi process
Outcome Measures Importance Validity Scientific
soundness
Usability Feasibility Ranking
CGI-SCH HIGH HIGH MED MED HIGH 1
Degree of involvement in vocational rehabilitation HIGH HIGH MED MED HIGH
Brief Psychiatric Rating Scale MED HIGH MED MED MED
Degree of Independent Living HIGH HIGH MED LOW MED
PANSS MED MED MED MED LOW
Service user Satisfaction Survey Responses HIGH LOW LOW MED MED
Development of Metabolic Syndrome/Diabetes HIGH HIGH MED MED MED
GAF Score MED MED MED MED MED
Process Adherence Measures
Percentage of Service users on Multiple Antipsychotics
(excluding clozapine)
MED HIGH MED HIGH MED 1
Percentage of service users who have metabolic monitoring
at recommended intervals
HIGH HIGH HIGH HIGH LOW 2
Percentage of service users referred for supported
employment/vocational services
HIGH MED HIGH HIGH HIGH 3
Percentage of service users referred to CBT for psychosis HIGH MED HIGH HIGH HIGH 4
Percentage of service users on recommended dosages
(within therapeutic range) of antipsychotic medication
MED MED MED HIGH LOW
Percentage of service users with a summary of previous
medication trials
MED MED MED HIGH MED
Percentage of first-episode service users who have
had a MRI brain
MED LOW LOW HIGH HIGH
Percentage of service users that have an annual physical exam MED LOW LOW HIGH HIGH
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Fig. 3 Screen shot of the carer assessment developed for social workers to complete with carers in order to comply with guideline
Fig. 4 Clinical practice guideline adherence from baseline (March 2014) through 12-month follow-up. Closed circles, monotherapy; open squares,
metabolic monitoring; closed triangles, vocational rehabilitation referral; open diamonds; cognitive behavioural therapy for psychosis referral
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Discussion
This paper describes the framework developed for the im-
plementation of the NICE CPG for schizophrenia at On-
tario Shores and describes clinician CPG adherence over
the 12 months following implementation. Strong evidence
regarding the implementation of CPGs in specialist men-
tal health care is scant, [22] but literature from general
mental health care supports systematic implementation of
guidelines rather than passive dissemination of informa-
tion [13, 23]. CPGs were more successfully implemented
in the presence of strong professional support, peer review
or quality circles [23, 24], with no increased or unmet
costs, systems in place for tracking implementation, and
clear guidance which reflected the clinical context [24].
Organizational support and culture [11, 12, 24] and com-
puterized clinical decision support [4, 23, 24] have strong
support as important facilitators of successful guideline
implementation. Therefore, the alignment of practices at
Ontario Shores with the NICE CPG for schizophrenia was
undertaken as an organization-wide, cost-neutral initia-
tive, involving senior management, interprofessional clin-
ical leaders, working groups composed of point of care
staff, and an informatics team. Informatics was highly in-
volved and workflows and decision support tools were
modified or created to conform to the CPG. Additionally,
customized clinical dashboards were developed to provide
feedback to clinicians regarding their adherence individu-
ally and in comparison to other practitioners and units. Fi-
nally, the CPG algorithms were posted on all clinical units
and learning modules were created for the internal staff
education site to promote adoption.
One of the goals of this project was to modify pre-
scribing practices to reduce antipsychotic polypharmacy,
which has been associated with increased side effects
with little evidence to support substantial benefit [25]. In
one study, the majority of service users who were
switched to monotherapy showed no differences in
PANSS scores or number of hospitalizations during the
6-month follow-up period compared to those prescribed
combinations of antipsychotics [26], suggesting no add-
itional benefit to polypharmacy. Nevertheless, polyphar-
macy remains prevalent worldwide, with 40–65 % of
service users prescribed multiple antipsychotics [27–30].
Appropriate implementation of guidance has been
shown to decrease the rate of antipsychotic polyphar-
macy prescription from 57 % at baseline to 16 % at 6-
year follow-up [31]. In the present study, monotherapy
rates were increased from 53.4 to 62.7 %, but this tended
to return toward baseline over the following months.
These prescribing practices are in line with international
averages [27–30]. Ontario Shores is a tertiary-care men-
tal health facility with a high proportion of treatment-
refractory service-users. Notwithstanding their engage-
ment with the CPG implementation, psychiatrists often
noted that they did not want to risk clinical decompen-
sation in some of their complex service users by switch-
ing from antipsychotic polypharmacy to monotherapy.
The largest decrease in polypharmacy (i.e. increased ad-
herence to guideline) occurred between April and May
2014 (polypharmacy decreased from 46.1 to 37.3 %),
which is when the clinical dashboard was first pushed
out to physicians, suggesting that awareness resulted in
improved prescribing practices. From the current data,
we are unable to determine why further improvements
were not made or sustained. Future studies need to
examine reasons for polypharmacy in order to create
targeted strategies for reduction.
Metabolic abnormalities, which increase the risk of de-
veloping cardiovascular diseases and type 2 diabetes
mellitus [32, 33], are common side effects of second
generation antipsychotic therapy. Since the rate of car-
diovascular mortality in men with schizophrenia is more
than double that of the general population [34, 35],
monitoring and subsequent management of cardiometa-
bolic risk factors is an important component to schizo-
phrenia treatment. A systematic review showed that,
overall, adherence to metabolic monitoring guidelines in
a population of service users on antipsychotic therapy
was inadequate to suboptimal, with monitoring of indi-
vidual risk factors ranging from 16 to 69 % [6]. In a clus-
ter randomized feasibility trial, implementation of
cardiovascular risk monitoring with a nurse-led inter-
vention resulted in monitoring of some risk factors in
approximately two thirds of service users compared to
approximately one third in the control group, which re-
ceived an education pack only with no specific leader-
ship [7]. Determination of overall cardiometabolic risk,
however, requires monitoring of all five components of
the metabolic syndrome in each individual. Automated
computer reminder systems increased monitoring of all
five metabolic risk factors in an outpatient setting from
5 to 15 % overall [4], but performance evaluation feed-
back was not generated for clinicians. In the present
study, 76.7 % of the metabolic risk factors were moni-
tored at the appropriate intervals prior to guideline im-
plementation and adherence increased slightly to 81.6 %
at 12 months follow-up. Importantly, the percentage of
service users who had all five metabolic risk factors
monitored increased from 36.0 % prior to CPG imple-
mentation to 56.3 % at 12-month follow-up (data not
shown). There was an increase in adherence when data
became available at the clinician level and was dissemi-
nated. This feedback appears to be an important compo-
nent of adherence to metabolic monitoring. The success
of this initiative was also likely a result of clinical deci-
sion support, which included automated reminders for
metabolic monitoring via an order set which was trig-
gered anytime a physician indicated that a service user
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was being prescribed or about to be prescribed an
antipsychotic.
According to the NICE guideline, CBT-P is a recom-
mended treatment for schizophrenia. In practice, referral
to CBT-P is generally low, though there is substantial vari-
ation across facilities. Reported CBT-P referral rates range
from 6.9 to 72 % [36–39], though the actual number of
service users receiving the intervention was lower. Imple-
mentation of the NICE CPG advising CBT-P at Ontario
Shores resulted in a referral rate of only around 7 %,
which remained low increasing to only 11.4 % over the
follow-up period. Berry and Haddock [40] identified a
number of barriers to CBT-P implementation, which
tended to cluster into three main categories: 1) capacity
(e.g. level and quality of training and supervision); 2) how
the service was configured (e.g. caseload size, responsibil-
ities of care teams, managerial priorities); and 3) service
user and carer barriers (e.g. a lack of desire for psycho-
logical interventions or preferring other types of interven-
tion). Many of these barriers were anticipated in the
development of the implementation process at Ontario
Shores, but efforts to mitigate barriers were not successful
and adherence remained low. Adherence to this guideline
may be improved by developing automated reflexive or-
ders at later points in the hospitalization rather than just
on admission. It is important to note that resources were
not a limiting factor in the availability of CBT-P in the
group format so additional education, analyses and
decision-support strategies should result in improved
utilization of CBT-P. Since Ontario Shores was unable to
implement 1:1 CBT-P for all service users as per the
guidelines, the effectiveness of group CBT for these ser-
vice users should be evaluated to assess whether this inter-
vention improves outcomes.
Supported employment programs have proven to be su-
perior to prevocational training for improving the likeli-
hood that people with mental illness will attain competitive
employment [41, 42]. Ontario Shores already had a robust
supported employment program in place for service users
as well as other vocational services for those who are not
ready for supported employment. Vocational counselors
work in partnership with the Ontario Disability Support
Program to assist service users in finding work within the
community. Automated referrals to vocational therapy via a
suggested order are triggered when a physician enters
schizophrenia as the primary diagnosis at admission. Voca-
tional therapy performs an assessment on each service user
referred with the goal of providing supported employment
when clinically appropriate. Similarly to CBT-P, admitting
physicians can deselect the suggested referral if they believe
the service-user would not benefit from the vocational ther-
apy assessment at the time of admission. More analysis is
required to determine if all service users who would benefit
are being offered supported employment.
Limitations
This paper describes Ontario Shores’ implementation of
the NICE CPGs for schizophrenia [21]. Some limitations
should be noted. The adherence data should be interpreted
with caution. Adherence numbers presented indicate only
the overall percentage of completed/referred tasks and do
not take into account reasons for non-adherence, which
could include not clinically indicated or service user/carer
refusal. Reasons for non-adherence to guidelines should be
documented and reported in the future. Additionally, ad-
herence rates may be an artifact of improved documenta-
tion rather than increased adherence to the CPG per se.
The reported variation in adherence measures (i.e. range
across units) should be interpreted with caution as qualify-
ing service users (i.e. those diagnosed with schizophrenia or
schizoaffective disorder) ranged from 1 to 25 per unit over
the 13 months of data collection (those with 0 qualifying
service users were not included).
The majority of individuals with schizophrenia are
treated in the community or acute care hospitals; hence,
the NICE CPG was developed based on evidence gener-
ated primarily in these settings. Ontario Shores is a spe-
cialty hospital providing services for complex and
serious mental illnesses, so the recommendations are
not appropriate for all of the services users treated at
this facility. A recent systematic review noted that guide-
lines should be adapted locally to account for values, re-
sources, context and feasibility [22]. The challenge for
the future will be to consider these issues to outline ap-
propriate adherence targets for each metric, while con-
sidering the unique composition of our service user
population.
While the specific programs and services initiated and
reported here may not be generalizable to all mental
health facilities, the general framework and tools should
be customizable to most circumstances. Our goal is to
create a collaborative network and to foster a continuous
cycle of learning to share experiences and develop a set
of tools for successful implementation of CPGs based on
learnings from numerous sites with varying levels of
care. A toolkit and workbook have been developed,
which provide access to the process used in implementa-
tion [43].
Throughout the implementation of CPGs at Ontario
Shores many lessons were learned. It was important to
have strong engagement with physicians and interprofes-
sional clinicians; high levels of transparency and justifi-
cation of processes was required to support physician
buy-in. Moreover, physician behavior was not the only
factor affecting adherence, as the interprofessional team
and service user choices could also have affected the
adherence score. Involvement of informatics to develop
structured templates, order sets, clinical panels,
decision-support and clinical scorecards was essential to
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promote adherence and to provide relevant feedback for
improvement.
Future research is needed to investigate the effects of
CPG implementation on relevant service user outcomes.
Reasons for non-adherence need to be examined in
order to develop targeted quality improvement initiatives
to increase adherence. Additionally, proper follow-up
procedures should be considered. In one study, despite
better adherence to metabolic monitoring with a nurse-
led implementation compared to education only, there
was no difference in the referral to relevant behavioral
interventions or prescription of indicated pharmaco-
logical treatments [7]. Although not measured in this
study, it is necessary for clinicians to respond appropri-
ately to reduce adverse metabolic sequelae if the moni-
toring results indicate increased risk.
Conclusions
In conclusion, this paper describes a promising strategy
to support the implementation of and adherence to
CPGs in specialized mental health. This project is a
starting point for collaborative network building, provid-
ing a framework and tool kit that can be customized to
meet organizational needs.
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